FDA Approves Tecentriq® as First Immunotherapy Regimen for Breast Cancer
A breakthrough therapy is offering unprecedented hope to women with metastatic triple negative breast.... Read More
Experts, Including Nobel Prize Winner, Discuss Importance of Discovery
The fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference was held last month in New.... Read More
It's a long way from rural Iowa to Nashville, but Meredith McKean, MD, MPH, has navigated it well, with a few stops in between. In June, McKean was named among the newest rese.... Read More
Lung cancer is no longer an automatic death sentence thanks in part to work being done in Nashville, including studies at Sarah Cannon Research Institute, the research arm of.... Read More
Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States (skin cancer aside). The American Cancer Society anticipates 95,270 new.... Read More